Using donor CAR T cells shows promise in treating myeloma patients in phase I trial
A team of medical specialists working at Memorial Sloan Kettering Cancer Center in New York has found that donated white blood cells can be used effectively as part of CAR T cell therapy to treat myeloma patients.